Skip to main content
Premium Trial:

Request an Annual Quote

Bioneer Receives CE IVD Mark for PCR Zika Detection Kit

NEW YORK (GenomeWeb) – South Korean molecular diagnostics firm Bioneer announced today that it has received CE IVD marking for its AccuPower ZIKV  (DENV, CHIKV) Multiplex Real-Time RT-PCR Zika virus detection kit.

The multiplex mosquito-borne virus panel is a qualitative nucleic acid assay that uses Bioneer's ExiStation Molecular Diagnostic System to rapidly test for Zika, Dengue, and Chikungunya simultaneously, the company said. The assay incorporates Bioneer's Dual-HotStart RT-PCR technologies, which include hotstart in both the PCR and reverse transcription steps, enhancing sensitivity and specificity. It can confirm infection within four hours of testing.

In 2014, Bioneer released a molecular test kit for Ebola that it had developed in collaboration with the Nigerian National Biotechnology Development Agency.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more